• NEW
    May 26, 2026

    Clinical development teams must manage trial complexity, fragmented data, slower patient recruitment, and tighter regulatory scrutiny, with AI options offering an appealing solution to these operational challenges. Everest Group’s report, Innovation Watch: AI Applications in Clinical…
  • See Us At
    March 16, 2026

      Join Nisarg Shah, Practice Director at Everest Group, for a webinar on Beyond Pilots: Scaling Trusted AI in Clinical Trial Documentation. AI adoption in clinical trials is accelerating, yet many organizations still struggle to move…
  • Discovery
    March 02, 2026

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world's leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • Discovery
    Feb. 27, 2026

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world's leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • State of the Market
    Feb. 25, 2026

    The clinical development technology market transform as life sciences enterprises increasingly rely on digital and AI-enabled solutions to manage rising costs, complex regulatory demands, and longer development cycles. This State of the Market report outlines how…
  • Video
    Feb. 10, 2026

    Everest Group’s PEAK Matrix® Assessment assesses RTSM providers through the lens of buyer impact and delivery capability. In this deep dive, Nisarg Shah, Practice Director, and Kayva Murki, Senior Analyst, analyze the RTSM provider market in…
  • Video
    Feb. 10, 2026

    The PEAK Matrix® Assessment provides a structured evaluation of RTSM providers’ strengths, scale, and differentiation in the market. Nisarg Shah, Practice Director, and Kayva Murki, Senior Analyst, explore the major growth drivers accelerating RTSM adoption. They…
  • Video
    Feb. 10, 2026

    Everest Group’s PEAK Matrix® Assessment evaluates RTSM providers based on market impact and vision & capability. In this video, Nisarg Shah, Practice Director, and Kayva Murki, Senior Analyst, unpack findings from the inaugural RTSM PEAK Matrix®…
  • Discovery
    Jan. 27, 2026

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world's leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • Discovery
    Jan. 12, 2026

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world's leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • Innovation Watch
    Jan. 08, 2026

    AI has emerged as a transformative force in clinical development, by enhancing decision-making, automating manual processes, and improving trial execution across the value chain. This report explores generative, agentic, and advanced AI’s growing influence in the…
  • Provider Compendium
    Dec. 30, 2025

    Enterprises are repositioning quality from a downstream testing activity to a strategic engineering capability embedded across the software development life cycle. As digital, cloud, and AI initiatives scale, expectations are moving beyond defect identification toward resilience,…
  • Provider Compendium
    Dec. 17, 2025

    Life sciences organizations are increasingly prioritizing automation, configurability, and real-time visibility to support modern clinical trial requirements. As adaptive designs, decentralized models, and global multi-protocol studies become more prevalent, the role of Randomization and Trial Supply…
  • Discovery
    Nov. 26, 2025

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world's leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • Discovery
    Nov. 26, 2025

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world's leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • Provider Compendium
    Nov. 25, 2025

    Life sciences enterprises are accelerating their shift to modern digital platforms to meet evolving demands for agility, patient-centricity, and regulatory compliance. Traditional ERP and CRM systems are giving way to cloud-based platforms that enable intelligent, connected…
  • PEAK Matrix®
    Nov. 25, 2025

    With global and adaptive clinical trials’ rising complexities, life sciences organizations are increasingly adopting intelligent Randomization and Trial Supply Management (RTSM) platforms to enhance operational efficiency, ensure regulatory compliance, and safeguard patient integrity. RTSM systems have…
  • LinkedIn Live
    Nov. 19, 2025

    In an evolving landscape where analyst relations (AR) shape market perception and business success, leaders continued to look for proven tactics embraced by experienced AR professionals. Everest Group’s Katrina Menzigian, along with industry experts from other…
  • Technology Awareness Deep Dive
    Nov. 13, 2025

    This comprehensive report explores the evolution, current landscape, and future trajectory of solar photovoltaic technologies, with a global perspective. It delves into the three key generations of solar cell technology – first-generation crystalline silicon-based cells, second-generation…

Items per page